clinical trial · NCT04196452
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
Bristol-Myers Squibb·—·active not recruiting·n = 10
MelanomaIpilimumab
brief summary
This is an observational, national, retrospective study consisting of pediatric patients with advanced (spread or unremoveable) melanoma identified in the DMTR in the Netherlands
started
Aug 12, 2019
primary completion
Feb 20, 2034
completion
Jul 24, 2034
last updated
Nov 20, 2025
official title
Long-term Follow-up of Ipilimumab-treated Pediatric Patients Enrolled in the Dutch Melanoma Treatment Registry (DMTR)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol